• Consensus Rating: N/A
  • Consensus Price Target: GBX 0
  • Forecasted Upside: NaN
  • Number of Analysts: 0
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
GBX 0
+0 (0.00%)

This chart shows the closing price for ABC by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Abcam Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for ABC and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for ABC

Analyst Price Target is GBX 0
This price target is based on 0 analysts offering 12 month price targets for Abcam in the last 3 months. The average price target is GBX 0, with a high forecast of GBX 0 and a low forecast of £100,000. The average price target represents a NaN upside from the last price of GBX 0.

This chart shows the closing price for ABC for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is N/A

The current consensus among 0 contributing investment analysts is to n/a stock in Abcam. This N/A consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
12/22/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
3/22/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
6/20/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
9/18/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
12/17/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
3/16/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
5/15/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
6/14/2024

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
5/10/2022Royal Bank of CanadaLower TargetOutperformGBX 1,950 ➝ GBX 1,700
3/24/2022Royal Bank of CanadaReiterated RatingOutperformGBX 1,950
3/16/2022JPMorgan Chase & Co.Lower TargetNeutralGBX 1,800 ➝ GBX 1,500
3/16/2022Berenberg BankReiterated RatingHoldGBX 1,400
3/15/2022Royal Bank of CanadaReiterated RatingOutperformGBX 1,950
2/28/2022Liberum CapitalLower TargetHoldGBX 1,450 ➝ GBX 1,250
2/4/2022Royal Bank of CanadaReiterated RatingOutperformGBX 1,950
1/20/2022Berenberg BankReiterated RatingHoldGBX 1,400
1/7/2022Royal Bank of CanadaReiterated RatingOutperformGBX 1,640
1/4/2022JPMorgan Chase & Co.Boost TargetNeutralGBX 1,650 ➝ GBX 1,800
9/14/2021Berenberg BankBoost TargetHoldGBX 1,350 ➝ GBX 1,400
8/4/2021Liberum CapitalBoost TargetHoldGBX 1,400 ➝ GBX 1,450
8/2/2021Berenberg BankReiterated RatingHoldGBX 1,350
6/22/2021Berenberg BankBoost TargetHoldGBX 1,300 ➝ GBX 1,350
3/10/2021Berenberg BankBoost TargetHoldGBX 1,180 ➝ GBX 1,300
3/9/2021JPMorgan Chase & Co.Lower TargetNeutralGBX 1,400 ➝ GBX 1,300
12/17/2020Peel HuntReiterated RatingHoldGBX 1,530
12/17/2020Peel HuntReiterated RatingHoldGBX 1,530
7/24/2020Royal Bank of CanadaLower TargetOutperformGBX 1,400 ➝ GBX 1,350
7/23/2020Liberum CapitalReiterated RatingHold
7/23/2020Peel HuntReiterated RatingAdd
7/10/2020JPMorgan Chase & Co.Boost TargetNeutralGBX 1,188 ➝ GBX 1,400
7/9/2020Royal Bank of CanadaBoost TargetOutperformGBX 1,300 ➝ GBX 1,400
7/2/2020Peel HuntReiterated RatingAdd
6/3/2020Peel HuntReiterated RatingAdd
5/1/2020Peel HuntReiterated RatingAdd
4/24/2020Peel HuntReiterated RatingAdd
4/20/2020Royal Bank of CanadaUpgradeOutperform
4/17/2020Peel HuntLower TargetAddGBX 1,250 ➝ GBX 1,220
4/17/2020Liberum CapitalLower TargetHoldGBX 1,290 ➝ GBX 1,260
4/7/2020Peel HuntReiterated RatingAdd
4/1/2020Peel HuntLower TargetAddGBX 1,470 ➝ GBX 1,250
3/20/2020Berenberg BankBoost TargetBuyGBX 1,330 ➝ GBX 1,450
3/18/2020Liberum CapitalBoost TargetHoldGBX 1,290 ➝ GBX 1,370
3/10/2020JPMorgan Chase & Co.Boost TargetNeutralGBX 1,134 ➝ GBX 1,188
3/9/2020Liberum CapitalReiterated RatingHoldGBX 1,370 ➝ GBX 1,290
3/4/2020Peel HuntReiterated RatingAdd
2/13/2020Peel HuntReiterated RatingAdd
2/5/2020Peel HuntReiterated RatingAdd
1/27/2020Peel HuntBoost TargetAddGBX 1,300 ➝ GBX 1,470
1/14/2020Peel HuntReiterated RatingAdd
1/10/2020Liberum CapitalReiterated RatingHoldGBX 1,230 ➝ GBX 1,370
1/6/2020Peel HuntReiterated RatingAdd
12/18/2019Panmure GordonDowngradeSell
12/18/2019Royal Bank of CanadaLower TargetSector PerformerGBX 1,300 ➝ GBX 1,250
12/5/2019Peel HuntReiterated RatingAdd
11/12/2019Royal Bank of CanadaReiterated RatingSector PerformerGBX 1,300
11/11/2019Liberum CapitalReiterated RatingHoldGBX 1,230
11/11/2019Peel HuntReiterated RatingAdd
11/4/2019Peel HuntReiterated RatingAdd
10/7/2019Peel HuntReiterated RatingAdd
9/30/2019Liberum CapitalInitiated CoverageHoldGBX 1,230
9/16/2019JPMorgan Chase & Co.Lower TargetNeutralGBX 1,144 ➝ GBX 1,134
9/9/2019Berenberg BankReiterated RatingBuyGBX 1,330
9/9/2019Peel HuntReiterated RatingAddGBX 1,430 ➝ GBX 1,300
9/2/2019Peel HuntReiterated RatingAdd
8/1/2019Peel HuntReiterated RatingAdd
7/22/2019Peel HuntLower TargetAddGBX 1,550 ➝ GBX 1,430
7/15/2019Peel HuntReiterated RatingAdd
7/3/2019Peel HuntReiterated RatingAdd
6/27/2019Peel HuntDowngradeAddGBX 1,330 ➝ GBX 1,550
(Data available from 6/14/2019 forward)

News Sentiment Rating

0.39 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 7 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
11/17/2023
  • 3 very positive mentions
  • 6 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
12/17/2023
  • 0 very positive mentions
  • 7 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
1/16/2024
  • 1 very positive mentions
  • 10 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
2/15/2024
  • 0 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
3/16/2024
  • 0 very positive mentions
  • 4 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
4/15/2024
  • 0 very positive mentions
  • 6 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
5/15/2024
  • 1 very positive mentions
  • 2 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
6/14/2024

Current Sentiment

  • 1 very positive mentions
  • 2 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Abcam logo
Abcam plc, a life science company, focuses on identifying, developing, and distributing reagents and tools for scientific research, diagnostics, and drug discovery. Its principal products include primary and secondary antibodies; conjugated antibodies and conjugation kits; singleplex and multiplex immunoassays; proteins and peptides that include cytokines; edited cell lines and lysates; and various other products, including cellular activity kits, miRNA kits, biochemicals, and cell signaling pathway tools. The company serves scientists and researchers in academic institutions and research institutes, as well as in pharmaceutical, biotechnology, and diagnostics companies. It has operations in the Americas, Europe, the Middle East, Africa, China, Japan, and rest of the Asia Pacific. The company sells its products online. Abcam plc was incorporated in 1998 and is headquartered in Cambridge, the United Kingdom.
Read More

Today's Range

Now: N/A

50 Day Range

MA: GBX 1,226
Low: 1,226
High: 1,226

52 Week Range

Now: N/A

Volume

6,372,291 shs

Average Volume

392,791 shs

Market Capitalization

£2.81 billion

P/E Ratio

20,433.33

Dividend Yield

0.91%

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of Abcam?

The following Wall Street research analysts have issued research reports on Abcam in the last year:
View the latest analyst ratings for ABC.

What is the current price target for Abcam?

0 Wall Street analysts have set twelve-month price targets for Abcam in the last year. has the lowest price target set, forecasting a price of £100,000 for Abcam in the next year.
View the latest price targets for ABC.

What is the current consensus analyst rating for Abcam?

Abcam currently has from Wall Street analysts. The stock has a consensus analyst rating of "N/A."
View the latest ratings for ABC.

What other companies compete with Abcam?

How do I contact Abcam's investor relations team?

Abcam's physical mailing address is 330 Cambridge Science Park, CAMBRIDGE, CB4 0FL, United Kingdom. The company's listed phone number is +44-1223-696000. The official website for Abcam is www.abcam.com. Learn More about contacing Abcam investor relations.